HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evaluation of the effects of intrathecal bupivacaine-dexmedetomidine for lumbar spine fusion: a double blinded randomized controlled study.

AbstractOBJECTIVE:
To evaluate the efficacy of intrathecal dexmedetomidine at improving the quality of the operative field, and prolonging the duration of sensory block, motor block, and postoperative analgesia during spinal surgery
PATIENTS AND METHODS:
This prospective, double-blinded, randomized controlled study included 52 patients undergoing an instrumented one-level posterolateral lumbar spine fusion for lumbar spondylolisthesis under spinal anesthesia. The patients were randomized into two groups: group D (n = 26) received 15 mg of hyperbaric bupivacaine with 5 μg of dexmedetomidine, while group P (n = 26) received 15 mg of hyperbaric bupivacaine only. The operative field quality score, blood loss volume, and the surgeon's satisfaction with the procedure were recorded. The onset time of the sensory block, time to reach peak sensory level, sensory and motor regression times, time to the first requirement of analgesia, sedation level, hemodynamics, and all postoperative complications were also recorded.
RESULTS:
The operative field quality and the surgeon's satisfaction scores (rated excellent) were significantly better in group D than in group P (p < 0.0001 and p = 0.003, respectively). Patients in group D had significantly longer sensory and motor regression times than patients in group P (p < 0.0001). The time to the first requirement of analgesia and the total dose of ketorolac was significantly longer and smaller, respectively, in group D than in group P (p < 0.0001).
CONCLUSIONS:
Intrathecal bupivacaine-dexmedetomidine improved the quality of the operative field, prolonged the duration of the sensory and motor block, prolonged postoperative analgesia, and produced minimal side effects.
AuthorsR A Salem, E I Darweesh, M A Wanis, A A Mohamed
JournalEuropean review for medical and pharmacological sciences (Eur Rev Med Pharmacol Sci) Vol. 19 Issue 23 Pg. 4542-8 (Dec 2015) ISSN: 2284-0729 [Electronic] Italy
PMID26698250 (Publication Type: Journal Article, Randomized Controlled Trial)
Chemical References
  • Anesthetics, Local
  • Dexmedetomidine
  • Bupivacaine
  • Ketorolac
Topics
  • Adult
  • Aged
  • Anesthesia, Spinal (adverse effects, methods)
  • Anesthetics, Local (administration & dosage, adverse effects)
  • Bupivacaine (administration & dosage, adverse effects)
  • Dexmedetomidine (administration & dosage, adverse effects)
  • Double-Blind Method
  • Drug Therapy, Combination
  • Female
  • Hemodynamics (drug effects)
  • Humans
  • Ketorolac (administration & dosage, adverse effects)
  • Lumbar Vertebrae (drug effects, surgery)
  • Male
  • Middle Aged
  • Pain Management (methods)
  • Pain, Postoperative (drug therapy)
  • Spinal Fusion (methods)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: